KING OF PRUSSIA, Pa., Feb. 21, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President, and Chief Financial Officer will present at the following conferences:
Monday, March 4, 2024 at 9:50am (ET), at the TD Cowen 44th Annual Health Care Conference in Boston, MA
Tuesday, March 12, 2024 at 1:05pm (ET) at the Barclays 26th Annual Global Healthcare Conference in Miami Beach, FL.
Live audio webcasts of the presentations will be available on the Company's website (www.uhs.com). For those unable to listen to the live webcast, replays of the presentations will be available on the Company's website for 90 days following the conferences.
Universal Health Services, Inc. is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico, and the United Kingdom.
| Last Trade: | US$198.18 |
| Daily Change: | 0.56 0.28 |
| Daily Volume: | 769,815 |
| Market Cap: | US$11.630B |
October 29, 2024 June 07, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
